Janna Heide,Agnes J Bilecz,Samarjit Patnaik,Maria Francesca Allega,Leonhard Donle,Kaiting Yang,Ethan Teich,Yan Li,Qiaoshan Lin,Ke Kong,Li Liu,Tae Gyun Yang,Ken Chih-Chien Cheng,Jonathan H Shrimp,Quinlin M Hanson,Min Shen,Hongmao Sun,Hardik Shah,Lisa Schweizer,Katarzyna Zawieracz,Andrea Olland,Andre White,Robert K Suto,Razzaq Alhunayan,Medine Taşdemir,Noa Longman,Hua Liang,Matthias Mann,Gordon M Stott,Matthew D Hall,Simon Schwörer,Ralph R Weichselbaum,András Piffkó,Ernst Lengyel
{"title":"NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity.","authors":"Janna Heide,Agnes J Bilecz,Samarjit Patnaik,Maria Francesca Allega,Leonhard Donle,Kaiting Yang,Ethan Teich,Yan Li,Qiaoshan Lin,Ke Kong,Li Liu,Tae Gyun Yang,Ken Chih-Chien Cheng,Jonathan H Shrimp,Quinlin M Hanson,Min Shen,Hongmao Sun,Hardik Shah,Lisa Schweizer,Katarzyna Zawieracz,Andrea Olland,Andre White,Robert K Suto,Razzaq Alhunayan,Medine Taşdemir,Noa Longman,Hua Liang,Matthias Mann,Gordon M Stott,Matthew D Hall,Simon Schwörer,Ralph R Weichselbaum,András Piffkó,Ernst Lengyel","doi":"10.1038/s41586-025-09303-5","DOIUrl":null,"url":null,"abstract":"Cancer-associated fibroblasts (CAFs) have a pivotal cancer-supportive role, yet CAF-targeted therapies are lacking1,2. Here, using spatial transcriptomics and single-cell RNA sequencing, we investigate the role of nicotinamide N-methyltransferase (NNMT) in high-grade serous ovarian cancer. Mechanistically, NNMT-induced H3K27me3 hypomethylation drives complement secretion from CAFs, attracting immunosuppressive myeloid-derived suppressor cells (MDSCs) to the tumour. Nnmt knockout in immunocompetent mice impairs tumour growth in syngeneic ovarian, breast and colon tumour models through enhanced CD8+ T cell activation. Using high-throughput screening, we develop a potent and specific NNMT inhibitor that reduces the tumour burden and metastasis in multiple mouse cancer models and restores immune checkpoint blockade efficacy by decreasing CAF-mediated recruitment of MDSCs and reinvigorating CD8+ T cell activation. Our findings establish NNMT as a central CAF regulator and a promising therapeutic target to mitigate immunosuppression in the tumour microenvironment.","PeriodicalId":18787,"journal":{"name":"Nature","volume":"107 1","pages":""},"PeriodicalIF":48.5000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1038/s41586-025-09303-5","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Cancer-associated fibroblasts (CAFs) have a pivotal cancer-supportive role, yet CAF-targeted therapies are lacking1,2. Here, using spatial transcriptomics and single-cell RNA sequencing, we investigate the role of nicotinamide N-methyltransferase (NNMT) in high-grade serous ovarian cancer. Mechanistically, NNMT-induced H3K27me3 hypomethylation drives complement secretion from CAFs, attracting immunosuppressive myeloid-derived suppressor cells (MDSCs) to the tumour. Nnmt knockout in immunocompetent mice impairs tumour growth in syngeneic ovarian, breast and colon tumour models through enhanced CD8+ T cell activation. Using high-throughput screening, we develop a potent and specific NNMT inhibitor that reduces the tumour burden and metastasis in multiple mouse cancer models and restores immune checkpoint blockade efficacy by decreasing CAF-mediated recruitment of MDSCs and reinvigorating CD8+ T cell activation. Our findings establish NNMT as a central CAF regulator and a promising therapeutic target to mitigate immunosuppression in the tumour microenvironment.
期刊介绍:
Nature is a prestigious international journal that publishes peer-reviewed research in various scientific and technological fields. The selection of articles is based on criteria such as originality, importance, interdisciplinary relevance, timeliness, accessibility, elegance, and surprising conclusions. In addition to showcasing significant scientific advances, Nature delivers rapid, authoritative, insightful news, and interpretation of current and upcoming trends impacting science, scientists, and the broader public. The journal serves a dual purpose: firstly, to promptly share noteworthy scientific advances and foster discussions among scientists, and secondly, to ensure the swift dissemination of scientific results globally, emphasizing their significance for knowledge, culture, and daily life.